Effect of Linagliptin on Insulin Sensitivity and Pancreatic Beta Cell Function in Patients With Type 2 Diabetes Mellitus

NCT02097342 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Insulin Sensitivity/Resistance

Interventions

DRUG: Linagliptin
DRUG: Placebo
DRUG: Voglibose

Sponsor

Post Graduate Institute of Medical Education and Research, Chandigarh